Gustavo A. Rosario Benitez

Array ( [id] => 5004931 [patent_doc_number] => 20070202501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Proteins Expressed In Ink Cells' [patent_app_type] => utility [patent_app_number] => 10/574045 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23666 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202501.pdf [firstpage_image] =>[orig_patent_app_number] => 10574045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4552692 [patent_doc_number] => 07820620 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Cripto antagonism of activin and TGF-b signaling' [patent_app_type] => utility [patent_app_number] => 10/940431 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 13757 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820620.pdf [firstpage_image] =>[orig_patent_app_number] => 10940431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404357 [patent_doc_number] => 07288250 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Monoclonal antibodies against HMGB1' [patent_app_type] => utility [patent_app_number] => 10/938992 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 54 [patent_no_of_words] => 24725 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288250.pdf [firstpage_image] =>[orig_patent_app_number] => 10938992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243584 [patent_doc_number] => 20050271663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Compositions and methods for treating inflammatory disorders' [patent_app_type] => utility [patent_app_number] => 10/925366 [patent_app_country] => US [patent_app_date] => 2004-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 90258 [patent_no_of_claims] => 158 [patent_no_of_ind_claims] => 134 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271663.pdf [firstpage_image] =>[orig_patent_app_number] => 10925366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539272 [patent_doc_number] => 20090221077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Process for producing cytotoxic lymphocytes' [patent_app_type] => utility [patent_app_number] => 10/568745 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 51021 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221077.pdf [firstpage_image] =>[orig_patent_app_number] => 10568745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4964843 [patent_doc_number] => 20080107663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Tri1 Cells for Use in Atherosclerosis' [patent_app_type] => utility [patent_app_number] => 11/660113 [patent_app_country] => US [patent_app_date] => 2004-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7091 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107663.pdf [firstpage_image] =>[orig_patent_app_number] => 11660113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7082676 [patent_doc_number] => 20050048056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Method for the preparation of molecules having antibody activity' [patent_app_type] => utility [patent_app_number] => 10/914015 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16148 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048056.pdf [firstpage_image] =>[orig_patent_app_number] => 10914015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7038873 [patent_doc_number] => 20050158307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Methods and compositions for treating autoimmune diseases or conditions' [patent_app_type] => utility [patent_app_number] => 10/898003 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18227 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158307.pdf [firstpage_image] =>[orig_patent_app_number] => 10898003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4463041 [patent_doc_number] => 07935343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Human antibody molecules for IL-13' [patent_app_type] => utility [patent_app_number] => 10/891972 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 39 [patent_no_of_words] => 34503 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935343.pdf [firstpage_image] =>[orig_patent_app_number] => 10891972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236036 [patent_doc_number] => 20070128192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Human antibody molecules for il-13' [patent_app_type] => utility [patent_app_number] => 10/564647 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 35717 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128192.pdf [firstpage_image] =>[orig_patent_app_number] => 10564647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769512 [patent_doc_number] => 20050266010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders' [patent_app_type] => utility [patent_app_number] => 10/886557 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9873 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266010.pdf [firstpage_image] =>[orig_patent_app_number] => 10886557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7082674 [patent_doc_number] => 20050048054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Lymphocytes; methods' [patent_app_type] => utility [patent_app_number] => 10/888437 [patent_app_country] => US [patent_app_date] => 2004-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11348 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048054.pdf [firstpage_image] =>[orig_patent_app_number] => 10888437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 252525 [patent_doc_number] => 07579157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Antibody selection method against IGF-IR' [patent_app_type] => utility [patent_app_number] => 10/886838 [patent_app_country] => US [patent_app_date] => 2004-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 17100 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579157.pdf [firstpage_image] =>[orig_patent_app_number] => 10886838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15225105 [patent_doc_number] => 10500257 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Method of selecting WT1 vaccine adaptive patient [patent_app_type] => utility [patent_app_number] => 10/562486 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13509 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10562486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7055634 [patent_doc_number] => 20050276807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Treatment of acne' [patent_app_type] => utility [patent_app_number] => 10/868262 [patent_app_country] => US [patent_app_date] => 2004-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13365 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20050276807.pdf [firstpage_image] =>[orig_patent_app_number] => 10868262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4657125 [patent_doc_number] => 20080025986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Methods of Treating Tnf-Mediated Disorders' [patent_app_type] => utility [patent_app_number] => 10/557647 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19198 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20080025986.pdf [firstpage_image] =>[orig_patent_app_number] => 10557647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7126897 [patent_doc_number] => 20050058641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Tolerance induction and maintenance in hematopoietic stem cell allografts' [patent_app_type] => utility [patent_app_number] => 10/852936 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21929 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20050058641.pdf [firstpage_image] =>[orig_patent_app_number] => 10852936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32503 [patent_doc_number] => 07785590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1)' [patent_app_type] => utility [patent_app_number] => 10/850270 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 12823 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785590.pdf [firstpage_image] =>[orig_patent_app_number] => 10850270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181278 [patent_doc_number] => 20040202659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Recombinant anti-GPIIb/IIIa antibodies' [patent_app_type] => new [patent_app_number] => 10/844424 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11960 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20040202659.pdf [firstpage_image] =>[orig_patent_app_number] => 10844424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057331 [patent_doc_number] => 09096676 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Antibodies to MASP-2' [patent_app_type] => utility [patent_app_number] => 10/556509 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17168 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 352 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10556509 [rel_patent_id] =>[rel_patent_doc_number] =>)